{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:08:34Z","timestamp":1793909314233,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-Level Talent Scientific Research Start-Up Project of the Affiliated Hospital of Guangdong Medical University","award":["GCC2021006"],"award-info":[{"award-number":["GCC2021006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35553-y","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:24:14Z","timestamp":1767997454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Engrailed 1 promotes immune evasion and chemoresistance in glioma through single cell and CeRNA network analyses"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhen","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"35553_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2016\u20132020. Neuro Oncol. 25, iv1\u2013iv99. https:\/\/doi.org\/10.1093\/neuonc\/noad149 (2023).","journal-title":"Neuro Oncol."},{"key":"35553_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 23, 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106 (2021).","journal-title":"Neuro Oncol."},{"key":"35553_CR3","doi-asserted-by":"publisher","unstructured":"Grochans, S. et al. Epidemiology of glioblastoma Multiforme-Literature review. Cancers (Basel). 14 https:\/\/doi.org\/10.3390\/cancers14102412 (2022).","DOI":"10.3390\/cancers14102412"},{"key":"35553_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/OP.22.00476","volume":"19","author":"R Kotecha","year":"2023","unstructured":"Kotecha, R., Odia, Y., Khosla, A. A. & Ahluwalia, M. S. Key clinical principles in the management of glioblastoma. JCO Oncol. Pract. 19, 180\u2013189. https:\/\/doi.org\/10.1200\/OP.22.00476 (2023).","journal-title":"JCO Oncol. Pract."},{"key":"35553_CR5","doi-asserted-by":"publisher","unstructured":"Ntafoulis, I., Koolen, S. L. W., Leenstra, S. & Lamfers, M. L. M. Drug Repurposing, a Fast-Track approach to develop effective treatments for glioblastoma. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14153705 (2022).","DOI":"10.3390\/cancers14153705"},{"key":"35553_CR6","doi-asserted-by":"publisher","unstructured":"Thenuwara, G., Curtin, J. & Tian, F. Advances in diagnostic tools and therapeutic approaches for gliomas: A comprehensive review. Sens. (Basel). 23 https:\/\/doi.org\/10.3390\/s23249842 (2023).","DOI":"10.3390\/s23249842"},{"key":"35553_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72, 409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"35553_CR8","doi-asserted-by":"publisher","first-page":"vdad009","DOI":"10.1093\/noajnl\/vdad009","volume":"5","author":"P Sharma","year":"2023","unstructured":"Sharma, P., Aaroe, A., Liang, J. & Puduvalli, V. K. Tumor microenvironment in glioblastoma: current and emerging concepts. Neurooncol Adv. 5, vdad009. https:\/\/doi.org\/10.1093\/noajnl\/vdad009 (2023).","journal-title":"Neurooncol Adv."},{"key":"35553_CR9","doi-asserted-by":"publisher","first-page":"1003651","DOI":"10.3389\/fimmu.2022.1003651","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Front. Immunol. 13, 1003651. https:\/\/doi.org\/10.3389\/fimmu.2022.1003651 (2022).","journal-title":"Front. Immunol."},{"key":"35553_CR10","doi-asserted-by":"publisher","first-page":"15242","DOI":"10.1073\/pnas.0602116103","volume":"103","author":"P Sgado","year":"2006","unstructured":"Sgado, P. et al. Slow progressive degeneration of nigral dopaminergic neurons in postnatal engrailed mutant mice. Proc. Natl. Acad. Sci. U S A. 103, 15242\u201315247. https:\/\/doi.org\/10.1073\/pnas.0602116103 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"35553_CR11","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1523\/JNEUROSCI.21-09-03126.2001","volume":"21","author":"HH Simon","year":"2001","unstructured":"Simon, H. H., Saueressig, H., Wurst, W. & Goulding, M. D. O\u2019Leary, D. D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21, 3126\u20133134. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-09-03126.2001 (2001).","journal-title":"J. Neurosci."},{"key":"35553_CR12","doi-asserted-by":"publisher","first-page":"e2308537","DOI":"10.1002\/advs.202308537","volume":"11","author":"J Xu","year":"2024","unstructured":"Xu, J. et al. Engrailed-1 promotes pancreatic cancer metastasis. Adv. Sci. (Weinh). 11, e2308537. https:\/\/doi.org\/10.1002\/advs.202308537 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"35553_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12935-024-03230-7","volume":"24","author":"Y Cui","year":"2024","unstructured":"Cui, Y. et al. EN1 promotes lung metastasis of salivary adenoid cystic carcinoma by regulating the PI3K-AKT pathway and epithelial-mesenchymal transition. Cancer Cell. Int. 24, 51. https:\/\/doi.org\/10.1186\/s12935-024-03230-7 (2024).","journal-title":"Cancer Cell. Int."},{"key":"35553_CR14","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1158\/0008-5472.CAN-18-3264","volume":"79","author":"G Peluffo","year":"2019","unstructured":"Peluffo, G. et al. EN1 is a transcriptional dependency in Triple-Negative breast cancer associated with brain metastasis. Cancer Res. 79, 4173\u20134183. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3264 (2019).","journal-title":"Cancer Res."},{"key":"35553_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3760\/cma.j.cn112152-20231026-00257","volume":"46","author":"N Zhao","year":"2024","unstructured":"Zhao, N. et al. [En1 promotes cell proliferation and migration via Hedgehog signaling pathway in esophageal squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi. 46, 99\u2013107. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20231026-00257 (2024).","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"35553_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"35553_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ydbio.2014.07.004","volume":"393","author":"JL Zagozewski","year":"2014","unstructured":"Zagozewski, J. L., Zhang, Q., Pinto, V. I., Wigle, J. T. & Eisenstat, D. D. The role of homeobox genes in retinal development and disease. Dev. Biol. 393, 195\u2013208. https:\/\/doi.org\/10.1016\/j.ydbio.2014.07.004 (2014).","journal-title":"Dev. Biol."},{"key":"35553_CR18","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1002\/ijc.33494","volume":"148","author":"F Xu","year":"2021","unstructured":"Xu, F. et al. HOXD13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1. Int. J. Cancer. 148, 3060\u20133070. https:\/\/doi.org\/10.1002\/ijc.33494 (2021).","journal-title":"Int. J. Cancer"},{"key":"35553_CR19","first-page":"1391","volume":"58","author":"AC Gao","year":"1998","unstructured":"Gao, A. C., Lou, W. & Isaacs, J. T. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Cancer Res. 58, 1391\u20131394 (1998).","journal-title":"Cancer Res."},{"key":"35553_CR20","doi-asserted-by":"publisher","first-page":"14905","DOI":"10.1074\/jbc.RA118.003913","volume":"293","author":"L Lin","year":"2018","unstructured":"Lin, L. et al. The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming. J. Biol. Chem. 293, 14905\u201314915. https:\/\/doi.org\/10.1074\/jbc.RA118.003913 (2018).","journal-title":"J. Biol. Chem."},{"key":"35553_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549\u2013555. https:\/\/doi.org\/10.1016\/s1471-4906(02)02302-5 (2002).","journal-title":"Trends Immunol."},{"key":"35553_CR22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ymthe.2020.11.024","volume":"29","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. M2 Macrophage-Derived exosomes promote angiogenesis and growth of pancreatic ductal adenocarcinoma by targeting E2F2. Mol. Ther. 29, 1226\u20131238. https:\/\/doi.org\/10.1016\/j.ymthe.2020.11.024 (2021).","journal-title":"Mol. Ther."},{"key":"35553_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","volume":"10","author":"Y Chen","year":"2017","unstructured":"Chen, Y., Zhang, S., Wang, Q. & Zhang, X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J. Hematol. Oncol. 10, 36. https:\/\/doi.org\/10.1186\/s13045-017-0408-0 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"35553_CR24","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41418-023-01202-4","volume":"30","author":"S Tan","year":"2023","unstructured":"Tan, S. et al. Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response. Cell. Death Differ. 30, 2104\u20132119. https:\/\/doi.org\/10.1038\/s41418-023-01202-4 (2023).","journal-title":"Cell. Death Differ."},{"key":"35553_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang, H. et al. Zeb1-induced metabolic reprogramming of Glycolysis is essential for macrophage polarization in breast cancer. Cell. Death Dis. 13, 206. https:\/\/doi.org\/10.1038\/s41419-022-04632-z (2022).","journal-title":"Cell. Death Dis."},{"key":"35553_CR26","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3389\/fimmu.2018.02737","volume":"9","author":"MC Brunner-Weinzierl","year":"2018","unstructured":"Brunner-Weinzierl, M. C. & Rudd, C. E. CTLA-4 and PD-1 control of T-Cell motility and migration: implications for tumor immunotherapy. Front. Immunol. 9, 2737. https:\/\/doi.org\/10.3389\/fimmu.2018.02737 (2018).","journal-title":"Front. Immunol."},{"key":"35553_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun, C., Mezzadra, R. & Schumacher, T. N. Regulation and function of the PD-L1 checkpoint. Immunity 48, 434\u2013452. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.014 (2018).","journal-title":"Immunity"},{"key":"35553_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","volume":"131","author":"B Rowshanravan","year":"2018","unstructured":"Rowshanravan, B., Halliday, N. & Sansom, D. M. CTLA-4: a moving target in immunotherapy. Blood 131, 58\u201367. https:\/\/doi.org\/10.1182\/blood-2017-06-741033 (2018).","journal-title":"Blood"},{"key":"35553_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/neuonc\/noac157","volume":"25","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells. Neuro Oncol. 25, 82\u201396. https:\/\/doi.org\/10.1093\/neuonc\/noac157 (2023).","journal-title":"Neuro Oncol."},{"key":"35553_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41065-023-00292-x","volume":"160","author":"YM Sun","year":"2023","unstructured":"Sun, Y. M. et al. Enhancer-driven transcription of MCM8 by E2F4 promotes ATR pathway activation and glioma stem cell characteristics. Hereditas 160, 29. https:\/\/doi.org\/10.1186\/s41065-023-00292-x (2023).","journal-title":"Hereditas"},{"key":"35553_CR31","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-14-3387","volume":"75","author":"C Bowen","year":"2015","unstructured":"Bowen, C., Zheng, T. & Gelmann, E. P. NKX3.1 suppresses TMPRSS2-ERG gene rearrangement and mediates repair of androgen Receptor-Induced DNA damage. Cancer Res. 75, 2686\u20132698. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3387 (2015).","journal-title":"Cancer Res."},{"key":"35553_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.02.026","volume":"374","author":"C Soret","year":"2016","unstructured":"Soret, C. et al. Distinct mechanisms for opposite functions of homeoproteins Cdx2 and HoxB7 in double-strand break DNA repair in colon cancer cells. Cancer Lett. 374, 208\u2013215. https:\/\/doi.org\/10.1016\/j.canlet.2016.02.026 (2016).","journal-title":"Cancer Lett."},{"key":"35553_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-981-13-7647-4_2","volume":"1141","author":"XABC Liu","year":"2019","unstructured":"Liu, X. A. B. C. & Family Transporters Adv. Exp. Med. Biol. 1141, 13\u2013100, doi:https:\/\/doi.org\/10.1007\/978-981-13-7647-4_2 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"35553_CR34","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.2174\/13816128113199990493","volume":"19","author":"RK Vadlapatla","year":"2013","unstructured":"Vadlapatla, R. K., Vadlapudi, A. D., Pal, D. & Mitra, A. K. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes. Curr. Pharm. Des. 19, 7126\u20137140. https:\/\/doi.org\/10.2174\/13816128113199990493 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"35553_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41420-022-01061-x","volume":"8","author":"J Xu","year":"2022","unstructured":"Xu, J., Xu, J., Liu, X. & Jiang, J. The role of lncRNA-mediated CeRNA regulatory networks in pancreatic cancer. Cell. Death Discov. 8, 287. https:\/\/doi.org\/10.1038\/s41420-022-01061-x (2022).","journal-title":"Cell. Death Discov"},{"key":"35553_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of CeRNA crosstalk and competition. Nature 505, 344\u2013352. https:\/\/doi.org\/10.1038\/nature12986 (2014).","journal-title":"Nature"},{"key":"35553_CR37","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Luo, M., Cui, X., O\u2019Connell, D. & Yang, Y. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a CeRNA. Cell. Death Differ. 29, 1850\u20131863. https:\/\/doi.org\/10.1038\/s41418-022-00970-9 (2022).","journal-title":"Cell. Death Differ."},{"key":"35553_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","volume":"19","author":"S Wen","year":"2020","unstructured":"Wen, S. et al. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol. Cancer. 19, 171. https:\/\/doi.org\/10.1186\/s12943-020-01293-4 (2020).","journal-title":"Mol. Cancer"},{"key":"35553_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/cac2.12534","volume":"44","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. Cancer Commun. (Lond). 44, 469\u2013490. https:\/\/doi.org\/10.1002\/cac2.12534 (2024).","journal-title":"Cancer Commun. (Lond)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35553-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35553-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:53:47Z","timestamp":1770198827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35553-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35553-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4913"}}